Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney Disease
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether once monthly (QM) dosing of darbepoetin
alfa is non-inferior to that of once every 2 week (Q2W) dosing of darbepoetin alfa for the
correction of anemia in patients with Chronic Kidney Disease who are not receiving dialysis.